FDA DEVICE FACTS
ANIMAS VIBE SYSTEM
Animas Corp.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The Animas Vibe System consists of the Animas Vibe Insulin Pump paired with the Dexcom G4 Platinum CGM sensor and transmitter.
The Animas Vibe Insulin Pump is intended for the continuous subcutaneous infusion of insulin for the management of insulin-requiring diabetes. It can be used solely for continuous insulin delivery or as part of the Animas Vibe System to receive and display continuous glucose measurements from the Dexcom G4 PLATINUM Sensor and Transmitter.
The Animas Vibe System’s continuous glucose monitoring (CGM) is indicated for detecting trends and tracking patterns in persons (age 2 and older) with diabetes, and is intended to complement, not replace, information obtained from standard home glucose monitoring devices. CGM aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long term therapy adjustments, which may minimize these excursions. Interpretation of results from the Dexcom G4 PLATINUM Sensor and Transmitter should be based on the trends and patterns seen with several sequential readings over time.
The Animas® Vibe™ System is intended for single patient use in persons age 2 and older and requires a prescription.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。